Adicet Bio announced that board member Andrew Sinclair is leaving and Michael Grissinger will join the Audit Committee.

Nov 13, 2026, 4:07 PM ETNew bossRead the original at SEC EDGAR

Neutral

Adicet Bio's board fell from 7 members to 6, and Michael Grissinger took committee roles. Sinclair's departure was not due to a disagreement, and the filing reports no change to company operations, so the news does not change Adicet's outlook.

ACET · Adicet Bio, Inc.

AI read · Neutral

The AI's read

The filing says Sinclair's departure was not tied to a disagreement about Adicet's operations, policies, or practices. Grissinger already served as a director and was found independent for the audit committee. The changes affect board duties, but the filing gives no reason to expect a change in Adicet's business outlook.

Get alerts for ACET

Follow Adicet Bio, Inc. (ACET) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ACET

Free on the App Store and Google Play, or on the web.